Selected research
Industry Research
Sufentanil (API) Industry Research Report 2026
Market perspective
The global Sufentanil (API) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sufentanil (API) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sufentanil (API) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sufentanil (API) include Janssen Pharmaceuticals, Kern Pharma, Hameln Rds, Cristalia and Cambrex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sufentanil (API) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sufentanil (API) Market by Company
Janssen Pharmaceuticals
Kern Pharma
Hameln Rds
Cristalia
Cambrex
Sufentanil (API) Segment by Type
Purity 98%
Purity 99%
Sufentanil (API) Segment by Application
Injection
Capsule
Sufentanil (API) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sufentanil (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sufentanil (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sufentanil (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98%
- Purity 99%
Applications
- Injection
- Capsule
Companies covered
- Janssen Pharmaceuticals
- Kern Pharma
- Hameln Rds
- Cristalia
- Cambrex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sufentanil (API) Market Size (2021-2032)
- 2.2.2 Global Sufentanil (API) Sales (2021-2032)
- 2.2.3 Global Sufentanil (API) Market Average Price (2021-2032)
- 2.3 Sufentanil (API) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 98%
- 2.3.3 Purity 99%
- 2.4 Sufentanil (API) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Capsule
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sufentanil (API) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sufentanil (API) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Sufentanil (API) Revenue of Manufacturers (2021-2026)
- 3.4 Global Sufentanil (API) Average Price by Manufacturers (2021-2026)
- 3.5 Global Sufentanil (API) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sufentanil (API), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sufentanil (API), Product Type & Application
- 3.8 Global Manufacturers of Sufentanil (API), Established Date
- 3.9 Global Sufentanil (API) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen Pharmaceuticals
- 4.1.1 Janssen Pharmaceuticals Company Information
- 4.1.2 Janssen Pharmaceuticals Business Overview
- 4.1.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
- 4.1.5 Janssen Pharmaceuticals Recent Developments
- 4.2 Kern Pharma
- 4.2.1 Kern Pharma Company Information
- 4.2.2 Kern Pharma Business Overview
- 4.2.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kern Pharma Sufentanil (API) Product Portfolio
- 4.2.5 Kern Pharma Recent Developments
- 4.3 Hameln Rds
- 4.3.1 Hameln Rds Company Information
- 4.3.2 Hameln Rds Business Overview
- 4.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hameln Rds Sufentanil (API) Product Portfolio
- 4.3.5 Hameln Rds Recent Developments
- 4.4 Cristalia
- 4.4.1 Cristalia Company Information
- 4.4.2 Cristalia Business Overview
- 4.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cristalia Sufentanil (API) Product Portfolio
- 4.4.5 Cristalia Recent Developments
- 4.5 Cambrex
- 4.5.1 Cambrex Company Information
- 4.5.2 Cambrex Business Overview
- 4.5.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cambrex Sufentanil (API) Product Portfolio
- 4.5.5 Cambrex Recent Developments
5 Global Sufentanil (API) Market Scenario by Region
- 5.1 Global Sufentanil (API) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sufentanil (API) Sales by Region: 2021-2032
- 5.2.1 Global Sufentanil (API) Sales by Region: 2021-2026
- 5.2.2 Global Sufentanil (API) Sales by Region: 2027-2032
- 5.3 Global Sufentanil (API) Revenue by Region: 2021-2032
- 5.3.1 Global Sufentanil (API) Revenue by Region: 2021-2026
- 5.3.2 Global Sufentanil (API) Revenue by Region: 2027-2032
- 5.4 North America Sufentanil (API) Market Facts & Figures by Country
- 5.4.1 North America Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sufentanil (API) Sales by Country (2021-2032)
- 5.4.3 North America Sufentanil (API) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sufentanil (API) Market Facts & Figures by Country
- 5.5.1 Europe Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sufentanil (API) Sales by Country (2021-2032)
- 5.5.3 Europe Sufentanil (API) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sufentanil (API) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sufentanil (API) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sufentanil (API) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sufentanil (API) Market Facts & Figures by Country
- 5.7.1 South America Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sufentanil (API) Sales by Country (2021-2032)
- 5.7.3 South America Sufentanil (API) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sufentanil (API) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sufentanil (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sufentanil (API) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sufentanil (API) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sufentanil (API) Sales by Type (2021-2032)
- 6.1.1 Global Sufentanil (API) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Sufentanil (API) Sales Market Share by Type (2021-2032)
- 6.2 Global Sufentanil (API) Revenue by Type (2021-2032)
- 6.2.1 Global Sufentanil (API) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sufentanil (API) Revenue Market Share by Type (2021-2032)
- 6.3 Global Sufentanil (API) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sufentanil (API) Sales by Application (2021-2032)
- 7.1.1 Global Sufentanil (API) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Sufentanil (API) Sales Market Share by Application (2021-2032)
- 7.2 Global Sufentanil (API) Revenue by Application (2021-2032)
- 7.2.1 Global Sufentanil (API) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sufentanil (API) Revenue Market Share by Application (2021-2032)
- 7.3 Global Sufentanil (API) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sufentanil (API) Value Chain Analysis
- 8.1.1 Sufentanil (API) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sufentanil (API) Production Mode & Process
- 8.2 Sufentanil (API) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sufentanil (API) Distributors
- 8.2.3 Sufentanil (API) Customers
9 Global Sufentanil (API) Analyzing Market Dynamics
- 9.1 Sufentanil (API) Industry Trends
- 9.2 Sufentanil (API) Industry Drivers
- 9.3 Sufentanil (API) Industry Opportunities and Challenges
- 9.4 Sufentanil (API) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst